spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gronholm, M.
Right arrow Articles by Carpen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gronholm, M.
Right arrow Articles by Carpen, O.

Journal of Cell Science, Vol 112, Issue 6 895-904, Copyright © 1999 by Company of Biologists


JOURNAL ARTICLES

Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin

M Gronholm, M Sainio, F Zhao, L Heiska, A Vaheri and O Carpen
Departments of Pathology and Virology, University of Helsinki, Haartman Institute, PO Box 21 (Haartmaninkatu 3), FIN-00014 Helsinki. mikaela.gronholm@helsinki.fi

Ezrin, radixin and moesin (ERM) are homologous proteins, which are linkers between plasma membrane components and the actin-containing cytoskeleton. The ERM protein family members associate with each other in a homotypic and heterotypic manner. The neurofibromatosis 2 (NF2) tumor suppressor protein merlin (schwannomin) is structurally related to ERM members. Merlin is involved in tumorigenesis of NF2-associated and sporadic schwannomas and meningiomas, but the tumor suppressor mechanism is poorly understood. We have studied the ability of merlin to self-associate and bind ezrin. Ezrin was coimmunoprecipitated with merlin from lysates of human U251 glioma cells and from COS-1 cells transfected with cDNA encoding for merlin isoform I. The interaction was further studied and the association domains were mapped with the yeast two-hybrid system and with blot overlay and affinity precipitation experiments. The heterotypic binding of merlin and ezrin and the homotypic association of merlin involves interaction between the amino- and carboxy-termini. The amino-terminal association domain of merlin involves residues 1-339 and has similar features with the amino-terminal association domain of ezrin. The carboxy-terminal association domain cannot be mapped as precisely as in ezrin, but it requires residues 585-595 and a more amino-terminal segment. Unlike ezrin, merlin does not require activation for self-association but native merlin molecules can interact with each other. Heterodimerization between merlin and ezrin, however, occurs only following conformational alterations in both proteins. These results biochemically connect merlin to the cortical cytoskeleton and indicate differential regulation of merlin from ERM proteins.


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Ruppelt, R. Mosenden, M. Gronholm, E. M. Aandahl, D. Tobin, C. R. Carlson, H. Abrahamsen, F. W. Herberg, O. Carpen, and K. Tasken
Inhibition of T Cell Activation by Cyclic Adenosine 5'-Monophosphate Requires Lipid Raft Targeting of Protein Kinase A Type I by the A-Kinase Anchoring Protein Ezrin
J. Immunol., October 15, 2007; 179(8): 5159 - 5168.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Muranen, M. Gronholm, A. Lampin, D. Lallemand, F. Zhao, M. Giovannini, and O. Carpen
The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton
Hum. Mol. Genet., July 15, 2007; 16(14): 1742 - 1751.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. C. Hughes and R. G. Fehon
Phosphorylation and activity of the tumor suppressor Merlin and the ERM protein Moesin are coordinately regulated by the Slik kinase
J. Cell Biol., October 23, 2006; 175(2): 305 - 313.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. I. McClatchey and M. Giovannini
Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin
Genes & Dev., October 1, 2005; 19(19): 2265 - 2277.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Alfthan, L. Heiska, M. Gronholm, G. H. Renkema, and O. Carpen
Cyclic AMP-dependent Protein Kinase Phosphorylates Merlin at Serine 518 Independently of p21-activated Kinase and Promotes Merlin-Ezrin Heterodimerization
J. Biol. Chem., April 30, 2004; 279(18): 18559 - 18566.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. T. Stickney, W. C. Bacon, M. Rojas, N. Ratner, and W. Ip
Activation of the Tumor Suppressor Merlin Modulates Its Interaction with Lipid Rafts
Cancer Res., April 15, 2004; 64(8): 2717 - 2724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gronholm, L. Vossebein, C. R. Carlson, J. Kuja-Panula, T. Teesalu, K. Alfthan, A. Vaheri, H. Rauvala, F. W. Herberg, K. Tasken, et al.
Merlin Links to the cAMP Neuronal Signaling Pathway by Anchoring the RI{beta} Subunit of Protein Kinase A
J. Biol. Chem., October 17, 2003; 278(42): 41167 - 41172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gautreau, B. T. Fievet, E. Brault, C. Antony, A. Houdusse, D. Louvard, and M. Arpin
Isolation and Characterization of an Aggresome Determinant in the NF2 Tumor Suppressor
J. Biol. Chem., February 14, 2003; 278(8): 6235 - 6242.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. R. Scoles, V. D. Nguyen, Y. Qin, C.-X. Sun, H. Morrison, D. H. Gutmann, and S.-M. Pulst
Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling
Hum. Mol. Genet., December 1, 2002; 11(25): 3179 - 3189.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A.-M. Bashour, J.-J. Meng, W. Ip, M. MacCollin, and N. Ratner
The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F-Actin Cytoskeletal Defects in Primary Human Schwannoma Cells
Mol. Cell. Biol., February 15, 2002; 22(4): 1150 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
O.-M. Mykkanen, M. Gronholm, M. Ronty, M. Lalowski, P. Salmikangas, H. Suila, and O. Carpen
Characterization of Human Palladin, a Microfilament-associated Protein
Mol. Biol. Cell, October 1, 2001; 12(10): 3060 - 3073.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
D. R. LaJeunesse, B. M. McCartney, and R. G. Fehon
A Systematic Screen for Dominant Second-Site Modifiers of Merlin/NF2 Phenotypes Reveals an Interaction With blistered/DSRF and scribbler
Genetics, June 1, 2001; 158(2): 667 - 679.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Khanna, J. Khan, P. Nguyen, J. Prehn, J. Caylor, C. Yeung, J. Trepel, P. Meltzer, and L. Helman
Metastasis-associated Differences in Gene Expression in a Murine Model of Osteosarcoma
Cancer Res., May 1, 2001; 61(9): 3750 - 3759.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
H. Morrison, L. S. Sherman, J. Legg, F. Banine, C. Isacke, C. A. Haipek, D. H. Gutmann, H. Ponta, and P. Herrlich
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
Genes & Dev., April 15, 2001; 15(8): 968 - 980.
[Abstract] [Full Text]


Home page
J. Med. Genet.Home page
D G. R Evans, M Sainio, and M. E Baser
Neurofibromatosis type 2
J. Med. Genet., December 1, 2000; 37(12): 897 - 904.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
P. F.M. van der Ven, S. Wiesner, P. Salmikangas, D. Auerbach, M. Himmel, S. Kempa, K. Haye{beta}, D. Pacholsky, A. Taivainen, R. Schroder, et al.
Indications for a Novel Muscular Dystrophy Pathway: {gamma}-Filamin, the Muscle-specific Filamin Isoform, Interacts with Myotilin
J. Cell Biol., October 9, 2000; 151(2): 235 - 248.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Sainio, J. Jaaskelainen, H. Pihlaja, and O. Carpen
Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus
Neurology, March 14, 2000; 54(5): 1132 - 1138.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Goutebroze, E. Brault, C. Muchardt, J. Camonis, and G. Thomas
Cloning and Characterization of SCHIP-1, a Novel Protein Interacting Specifically with Spliced Isoforms and Naturally Occurring Mutant NF2 Proteins
Mol. Cell. Biol., March 1, 2000; 20(5): 1699 - 1712.
[Abstract] [Full Text]


Home page
DevelopmentHome page
B. McCartney, R. Kulikauskas, D. LaJeunesse, and R. Fehon
The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation
Development, January 3, 2000; 127(6): 1315 - 1324.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C. Gonzalez-Agosti, T. Wiederhold, M. E. Herndon, J. Gusella, and V. Ramesh
Interdomain Interaction of Merlin Isoforms and Its Influence on Intermolecular Binding to NHE-RF
J. Biol. Chem., November 26, 1999; 274(48): 34438 - 34442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Nguyen, D. Reczek, and A. Bretscher
Hierarchy of Merlin and Ezrin N- and C-terminal Domain Interactions in Homo- and Heterotypic Associations and Their Relationship to Binding of Scaffolding Proteins EBP50 and E3KARP
J. Biol. Chem., March 2, 2001; 276(10): 7621 - 7629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Jannatipour, P. Dion, S. Khan, H. Jindal, X. Fan, J. Laganiere, A. H. Chishti, and G. A. Rouleau
Schwannomin Isoform-1 Interacts with Syntenin via PDZ Domains
J. Biol. Chem., August 24, 2001; 276(35): 33093 - 33100.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 1999